Drug approvals

FILE - In this Oct. 17, 2018, file photo a depiction of a cannabis bud drops from the ceiling at Leafly's countdown party in Toronto as midnight passes and marks the first day of the legalization of cannabis across Canada. The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Canada ushered in broad legalization, U.S. drug regulators approved the first cannabis-based drug and investors pumped in billions of dollars. (Chris Young/The Canadian Press via AP, File)
December 27, 2018 - 3:44 pm
PORTLAND, Ore. (AP) — The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Liberal California became the largest legal U.S. marketplace, conservative Utah and...
Read More
FILE - In this Jan. 18, 2017 photo marijuana is displayed for sale at a shop in Juneau, Alaska. Alaska regulators approved rules for onsite consumption of marijuana at specially designated shops on Thursday, Dec. 20, 2018, a significant step for the cannabis industry after years of debate. (AP Photo/Mark Thiessen, File)
December 20, 2018 - 7:27 pm
JUNEAU, Alaska (AP) — Alaska regulators on Thursday approved rules for onsite consumption of marijuana at specially designated shops, a significant step for the cannabis industry in the state after years of debate. The 3-2 vote by the Marijuana Control Board does not mean people can light up at...
Read More
This undated product image provided by Genentech shows a box for Xofluza, a pill for shortening the duration and easing symptoms of the flu. U.S. health regulators have approved the first new type of flu drug in two decades. The approval on Wednesday, Oct. 24, 2018, of Roche’s Xofluza comes ahead of this winter’s flu season. (Genentech via AP)
October 24, 2018 - 2:09 pm
TRENTON, N.J. (AP) — U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can reduce severity and shorten duration of flu symptoms...
Read More
October 19, 2018 - 8:41 am
LONDON (AP) — Europe's drug regulator has recommended approving the first vaccine for dengue despite concerns about the vaccine's wide use and a lawsuit in the Philippines alleging that it was linked to three deaths. The European Medicines Agency said Friday it had adopted a "positive opinion" of...
Read More
FILE - This Sept. 13, 2016, file photo, shows a selection of Johnson & Johnson brand first aid products arranged for a photo in Surfside, Fla. Johnson & Johnson reports earnings Tuesday, Oct. 16, 2018. (AP Photo/Wilfredo Lee, File)
October 16, 2018 - 8:07 am
A jump in prescription drug sales and a sharply reduced tax bill boosted Johnson & Johnson's third-quarter sales and profit, which beat Wall Street expectations. The world's biggest maker of health care products on Tuesday also slightly raised its profit forecast for the year. The New Brunswick...
Read More
October 02, 2018 - 6:55 pm
TRENTON, N.J. (AP) — U.S. regulators have approved a modernized version of a decades-old antibiotic used to treat a number of infections. Paratek Pharmaceuticals' Nuzyra (noo-ZAHY'-ruh) was designed to overcome the problem of resistance to tetracycline, an antibiotic widely used until recent years...
Read More
August 16, 2018 - 5:41 pm
WASHINGTON (AP) — U.S. health officials on Thursday approved a new generic version of EpiPen, the emergency allergy medication that triggered a public backlash due to its rising price tag. The new version from Teva Pharmaceuticals is the first that will be interchangeable with the original penlike...
Read More
This undated image provided by AbbVie in July 2018 shows packaging for the company's drug Orilissa (elagolix). On Tuesday, July 24, 2018, the company said that The Food and Drug Administration approved its the drug for pain during menstruation and at other times. (AbbVie via AP)
July 24, 2018 - 12:07 pm
TRENTON, N.J. (AP) — A new treatment for pain caused by endometriosis was approved Tuesday by U.S. regulators. The common condition involves abnormal tissue growth from the uterus that can cause severe pain and infertility. Drugmaker Abbvie said the Food and Drug Administration approved the drug,...
Read More
FILE - This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatment, to prevent relapses of malaria. (AP Photo/Kirsty Wigglesworth, File)
July 20, 2018 - 5:58 pm
U.S. regulators have approved a simpler, one-dose treatment to prevent relapses of malaria. Standard treatment takes two weeks and many patients don't finish taking all the doses. Malaria is caused by parasites that are spread through mosquito bites. The parasites can remain dormant in the liver...
Read More
This 1975 microscope image made available by the Centers for Disease Control and Prevention shows a cluster of smallpox viruses. On Friday, July 13, 2018, U.S. regulators announced the approval of the first treatment for smallpox _ a deadly disease that was wiped out four decades ago _ in case the virus is used in a terror attack. (Fred Murphy/CDC via AP)
July 13, 2018 - 7:08 pm
U.S. regulators Friday approved the first treatment for smallpox — a deadly disease that was wiped out four decades ago — in case the virus is used in a terror attack. Smallpox, which is highly contagious, was eradicated worldwide by 1980 after a huge vaccination campaign. But people born since...
Read More

Pages